Analystreport

Stemline Therapeutics Inc (NASDAQ: STML) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies.

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations